AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics, today announced the appointment of Chris Earl, Ph.D., an experienced entrepreneur and investor, Corey S. Goodman, Ph.D., Managing Director and co-founder of venBio, and Evan Melrose, M.D., founder and Managing Director of PTV Sciences, as outside Directors to its Board. These outside directors join Paul Lammers, M.D., President and CEO, and Matt Winkler, Ph.D., Mirna’s Founder and Chairman of the Board.
